117 related articles for article (PubMed ID: 8817392)
1. Conditions affecting the isolation of human umbilical cord blood CD34+ cells.
Case J; Rice A; Vowels M
J Hematother; 1996 Jun; 5(3):255-60. PubMed ID: 8817392
[TBL] [Abstract][Full Text] [Related]
2. Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems.
de Wynter EA; Coutinho LH; Pei X; Marsh JC; Hows J; Luft T; Testa NG
Stem Cells; 1995 Sep; 13(5):524-32. PubMed ID: 8528102
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection.
Nagler A; Peacock M; Tantoco M; Lamons D; Okarma TB; Okrongly DA
Exp Hematol; 1994 Nov; 22(12):1134-40. PubMed ID: 7523166
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization of immunomagnetically purified umbilical cord blood CD34+ cells.
Belvedere O; Feruglio C; Malangone W; Bonora ML; Donini A; Dorotea L; Tonutti E; Rinaldi C; Pittino M; Baccarani M; Del Frate G; Biffoni F; Sala P; Hilbert DM; Degrassi A
Blood Cells Mol Dis; 1999; 25(3-4):141-6. PubMed ID: 10575539
[TBL] [Abstract][Full Text] [Related]
5. Cytokine mediated expansion of human umbilical cord blood CD34+ cells: comparison of the use of partially purified and pure CD34+ target cells.
Case J; Rice A; Vowels M
Hematol Cell Ther; 1997 Aug; 39(4):193-7. PubMed ID: 9352327
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC.
Forraz N; Pettengell R; McGuckin CP
Stem Cells; 2004; 22(1):100-8. PubMed ID: 14688396
[TBL] [Abstract][Full Text] [Related]
7. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
Huang S; Law P; Young D; Ho AD
Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
[TBL] [Abstract][Full Text] [Related]
8. [Phenotypical determinants of stem cell subpopulations derived from human umbilical cord blood].
Rodríguez VM; Cuéllar A; Cuspoca LM; Contreras CL; Mercado M; Gómez A
Biomedica; 2006 Mar; 26(1):51-60. PubMed ID: 16929903
[TBL] [Abstract][Full Text] [Related]
9. Two CD34+ stem cells from umbilical cord blood enrichment methods.
Pafumi C; Bosco P; Cavallaro A; Farina M; Leonardi I; Pernicone G; Bandiera S; Russo A; Giardina P; Chiarenza M; Calogero AE
Pediatr Hematol Oncol; 2002 Jun; 19(4):239-45. PubMed ID: 12051590
[TBL] [Abstract][Full Text] [Related]
10. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of immunophenotype of hematopoietic stem/progenitor cells in human umbilical cord blood with flow cytometry and its significance].
Guo R; Ma B; Zou D
Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):426-8. PubMed ID: 11718095
[TBL] [Abstract][Full Text] [Related]
12. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
[TBL] [Abstract][Full Text] [Related]
13. Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets.
de Wynter EA; Nadali G; Coutinho LH; Testa NG
Stem Cells; 1996 Sep; 14(5):566-76. PubMed ID: 8888497
[TBL] [Abstract][Full Text] [Related]
14. [Isolation and enrichment of hematopoietic stem/progenitor cells from human placenta tissue].
Zhang T; Chen DX; Fang N; Liu ZL; Qi Y; Liu JW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):955-8. PubMed ID: 17096896
[TBL] [Abstract][Full Text] [Related]
15. A novel method of CD34+ cell separation from umbilical cord blood.
Mehrishi JN; Bakács T
Transfusion; 2013 Nov; 53(11):2675-80. PubMed ID: 23432618
[TBL] [Abstract][Full Text] [Related]
16. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer.
Kadereit S; Deeds LS; Haynesworth SE; Koc ON; Kozik MM; Szekely E; Daum-Woods K; Goetchius GW; Fu P; Welniak LA; Murphy WJ; Laughlin MJ
Stem Cells; 2002; 20(6):573-82. PubMed ID: 12456965
[TBL] [Abstract][Full Text] [Related]
17. A simple filtration system for red blood cell depletion and volume reduction in routine processing of human umbilical cord blood.
Sowemimo-Coker SO; Andrade F; Kim A; Pesci S
Vox Sang; 2009 Feb; 96(2):138-45. PubMed ID: 19152606
[TBL] [Abstract][Full Text] [Related]
18. Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.
Almici C; Carlo-Stella C; Wagner JE; Mangoni L; Garau D; Re A; Giachetti R; Cesana C; Rizzoli V
Bone Marrow Transplant; 1997 Jun; 19(11):1079-84. PubMed ID: 9193749
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Ceprate LC34 affinity system for the enrichment of CD34+ hematopoietic stem cells from cord blood.
Kögler G; Somville T; Werner P
Blood Cells; 1994; 20(2-3):371-5. PubMed ID: 7538341
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells from CD34(-) human umbilical cord blood.
Lu X; Alshemali S; de Wynter EA; Dickinson AM
Transfus Med; 2010 Jun; 20(3):178-84. PubMed ID: 19948008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
